LD 1215 LR 740(03)
An Act to End the Sale of Flavored Tobacco Products
Fiscal Note for Bill as Amended by Committee Amendment " "
Committee: Health and Human Services
Fiscal Note Required: Yes
Fiscal Note
FY 2023-24 FY 2024-25 Projections  FY 2025-26 Projections  FY 2026-27
Net Cost (Savings)
General Fund $264,400 $639,150 $661,000 $683,850
General Fund ($264,400) ($639,150) ($661,000) ($683,850)
Other Special Revenue Funds ($1,600) ($3,850) ($4,000) ($4,150)
Correctional and Judicial Impact Statements
Establishes new civil violations. The additional workload associated with the minimal number of new cases filed in the court system does not require additional funding at this time.
The collection of additional fines will increase General Fund or other dedicated revenue by minor amounts.
Fiscal Detail and Notes
This bill prohibits the sale of flavored vaping liquid that has not obtained a tobacco product clearance order or a modified risk tobacco product order from the United States Food and Drug Administration. It will reduce General Fund revenue from the sales tax and tobacco products tax by $264,400 in fiscal year 2023-24 and $639,150 in fiscal year 2024-25. The decrease in sales tax revenue will reduce Local Government Fund revenue by $1,600 in fiscal year 2023-24 and $3,850 in fiscal year 2024-25. These estimates assume an effective date of January 1, 2024.
Any additional costs to the Department of Health and Human Services to adopt the changes in this bill are expected to be minor and can be absorbed within existing budgeted resources.